$540,000.00 in Sales Expected for Anterix Inc. (NASDAQ:ATEX) This Quarter

Wall Street analysts forecast that Anterix Inc. (NASDAQ:ATEX) will announce sales of $540,000.00 for the current quarter, Zacks reports. Two analysts have provided estimates for Anterix’s earnings, with the highest sales estimate coming in at $680,000.00 and the lowest estimate coming in at $400,000.00. Anterix posted sales of $240,000.00 in the same quarter last year, which suggests a positive year-over-year growth rate of 125%. The company is expected to report its next quarterly earnings results on Monday, February 14th.

According to Zacks, analysts expect that Anterix will report full-year sales of $1.70 million for the current financial year, with estimates ranging from $980,000.00 to $2.55 million. For the next year, analysts forecast that the firm will post sales of $13.65 million, with estimates ranging from $4.04 million to $29.31 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that cover Anterix.

Anterix (NASDAQ:ATEX) last released its quarterly earnings results on Wednesday, November 3rd. The company reported ($0.67) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.68) by $0.01. The business had revenue of $0.18 million for the quarter, compared to analyst estimates of $0.18 million. Anterix had a negative return on equity of 22.27% and a negative net margin of 6,017.29%. During the same period in the prior year, the company earned ($0.94) EPS.

ATEX has been the subject of a number of research reports. Morgan Stanley increased their target price on Anterix from $51.00 to $65.00 and gave the stock an “equal weight” rating in a report on Wednesday, August 4th. Zacks Investment Research upgraded Anterix from a “hold” rating to a “buy” rating and set a $72.00 target price for the company in a report on Monday. One research analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $65.67.

Anterix stock traded down $0.13 during mid-day trading on Friday, hitting $61.51. 816,911 shares of the company’s stock were exchanged, compared to its average volume of 135,659. The firm has a market capitalization of $1.13 billion, a P/E ratio of -23.21 and a beta of 0.44. Anterix has a fifty-two week low of $28.60 and a fifty-two week high of $66.55. The company’s 50 day simple moving average is $61.18 and its 200-day simple moving average is $57.84.

In other news, insider Gena L. Ashe sold 997 shares of the firm’s stock in a transaction dated Friday, November 5th. The stock was sold at an average price of $61.96, for a total value of $61,774.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Hamid Akhavan acquired 2,500 shares of the firm’s stock in a transaction dated Tuesday, November 16th. The stock was bought at an average price of $61.04 per share, with a total value of $152,600.00. The disclosure for this purchase can be found here. In the last quarter, insiders have sold 62,831 shares of company stock valued at $3,566,350. Corporate insiders own 4.05% of the company’s stock.

A number of institutional investors have recently bought and sold shares of the stock. Morgan Stanley grew its holdings in Anterix by 6.1% during the second quarter. Morgan Stanley now owns 1,403,221 shares of the company’s stock worth $84,179,000 after purchasing an additional 80,091 shares during the period. BlackRock Inc. lifted its position in Anterix by 1.4% during the third quarter. BlackRock Inc. now owns 840,313 shares of the company’s stock worth $51,007,000 after acquiring an additional 11,855 shares during the last quarter. Heard Capital LLC lifted its position in Anterix by 14.5% during the third quarter. Heard Capital LLC now owns 424,050 shares of the company’s stock worth $25,740,000 after acquiring an additional 53,860 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in Anterix by 9.7% during the third quarter. Dimensional Fund Advisors LP now owns 318,780 shares of the company’s stock worth $19,350,000 after acquiring an additional 28,104 shares during the last quarter. Finally, State Street Corp lifted its position in Anterix by 2.6% during the second quarter. State Street Corp now owns 240,469 shares of the company’s stock worth $14,426,000 after acquiring an additional 6,181 shares during the last quarter. Institutional investors and hedge funds own 83.99% of the company’s stock.

About Anterix

Anterix, Inc operates as a wireless communications company. The firm focuses on commercializing spectrum assets to enable targeted utility and critical infrastructure customers to deploy private broadband networks, technologies and solutions. It’s solutions include Private LTE and Active Ecosystem. The company was founded by Peter Joel Lasensky and Richard Edward Rohmann in 1997 and is headquartered in Woodland Park, NJ.

Read More: What are the reasons investors use put options?

Get a free copy of the Zacks research report on Anterix (ATEX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Anterix (NASDAQ:ATEX)

Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.